Platform Features
Platform Features
Features
Investment Products
Private Wealth Management
Trading Tools
Market Data Services
Analysis Tools
News Services
For Developers
Account Types
For Individuals
For Institutions
Café
More
Log in / Sign up
© 2026 Longbridge|
Terms of Service
Privacy Policy
Disclaimer
OKYO Pharma
OKYO
--
--
Start trading
Overview
Overview
Options
Options
News
News
Posts
Posts
Financials
Financials
Forecast
Forecast
Valuation
Valuation
Shareholders
Shareholders
Profile
Profile
Earnings
Revenue Breakdown
Financial Score
Key factors
Income Statement
Balance Sheet
Cash Flow
Shareholder return
Earnings
Revenue Breakdown
Financial Score
Key factors
Income Statement
Balance Sheet
Cash Flow
Shareholder return
Q4 FY2026 Earnings
Quarterly
Financial report interval: 2025.12.31 - 2026.03.31
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA
--
0.00B
--
--
--
EBIT
TBA
--
-0.00B
--
--
--
EPS
TBA
--
-0.03
--
--
--
Revenue
Actual
Estimate
Unit: USD
qf
EBIT
Actual
Estimate
Unit: USD
qf
Net income
GAAP
Normalized
GAAP
Normalized
Actual
Estimate
Unit: USD
qf
EPS
GAAP
Normalized
GAAP
Normalized
Actual
Estimate
Unit: USD
qf